Corporate Profile

We are a clinical stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

More
ANAB (Common Stock) $123.12 Stock is Up 3.69 (3.09%)02/23/18 4:00 p.m. ET
Stock chart for: ANAB.O.  Currently trading at $123.12 with a 52 week high of $134.00 and a 52 week low of $18.15.
Data provided by Nasdaq. Minimum 15 minutes delayed.




Upcoming Events


  |   |   |   |   |